Page 718 - Read Online

Wang et al. Hepatoma Res 2020;6:61 I http://dx.doi.org/10.20517/2394-5079.2020.55 Page 13 of 15

with flowing blood. Proc Natl Acad Sci U S A 2000;97:14608-13.
19. Mohme M, Riethdorf S, Pantel K. Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape. Nat Rev
Clin Oncol 2017;14:155-67.
20. Liberko M, Kolostova K, Bobek V. Essentials of circulating tumor cells for clinical research and practice. Crit Rev Oncol Hematol
2013;88:338-56.
21. Kim MY, Oskarsson T, Acharyya S, Nguyen DX, Zhang XH, et al. Tumor self-seeding by circulating cancer cells. Cell 2009;139:1315-26.
22. Coumans FA, Siesling S, Terstappen LW. Detection of cancer before distant metastasis. BMC Cancer 2013;13:1-12.
23. Ebright RY, Lee S, Wittner BS, Niederhoffer KL, Nicholson BT, et al. Deregulation of ribosomal protein expression and translation
promotes breast cancer metastasis. Science 2020;367:1468-73.
24. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. The epithelial-mesenchymal transition generates cells with properties of stem
cells. Cell 2008;133:704-15.
25. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 2009;119:1417-9.
26. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and
mesenchymal composition. Science 2013;339:580-4.
27. Sun YF, Guo W, Xu Y, Shi YH, Gong ZJ, et al. Circulating tumor cells from different vascular sites exhibit spatial heterogeneity in
epithelial and mesenchymal composition and distinct clinical significance in hepatocellular carcinoma. Clin Cancer Res 2018;24:547-59.
28. Padmanaban V, Krol I, Suhail Y, Szczerba BM, Aceto N, et al. E-cadherin is required for metastasis in multiple models of breast cancer.
Nature 2019;573:439-44.
29. Thompson EW, Haviv I. The social aspects of EMT-MET plasticity. Nat Med 2011;17:1048-9.
30. Aceto N. Bring along your friends: homotypic and heterotypic circulating tumor cell clustering to accelerate metastasis. Biomed J
2020;43:18-23.
31. Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, et al. Circulating tumor cell clusters are oligoclonal precursors of breast
cancer metastasis. Cell 2014;158:1110-22.
32. Manjunath Y, Upparahalli SV, Suvilesh KN, Avella DM, Kimchi ET, et al. Circulating tumor cell clusters are a potential biomarker for
detection of non-small cell lung cancer. Lung Cancer 2019;134:147-50.
33. Wang C, Mu Z, Chervoneva I, Austin L, Ye Z, et al. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic
breast cancer. Breast Cancer Res Treat 2017;161:83-94.
34. Wang L, Li Y, Xu J, Zhang A, Wang X, et al. Quantified postsurgical small cell size CTCs and EpCAM(+) circulating tumor stem cells
with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse. Cancer Lett 2018;412:99-107.
35. Gkountela S, Castro-Giner F, Szczerba BM, Vetter M, Landin J, et al. Circulating tumor cell clustering shapes DNA methylation to enable
metastasis seeding. Cell 2019;176:98-112.e14.
36. Szczerba BM, Castro-Giner F, Vetter M, Krol I, Gkountela S, et al. Neutrophils escort circulating tumour cells to enable cell cycle
progression. Nature 2019;566:553-7.
37. Labuschagne CF, Cheung EC, Blagih J, Domart MC, Vousden KH. Cell clustering promotes a metabolic switch that supports metastatic
colonization. Cell Metab 2019;30:720-34.e5.
38. Liu X, Taftaf R, Kawaguchi M, Chang YF, Chen W, et al. Homophilic CD44 interactions mediate tumor cell aggregation and polyclonal
metastasis in patient-derived breast cancer models. Cancer Discov 2019;9:96-113.
39. Guo J, Yao F, Lou Y, Xu C, Xiao B, et al. Detecting carcinoma cells in peripheral blood of patients with hepatocellular carcinoma by
immunomagnetic beads and rt-PCR. J Clin Gastroenterol 2007;41:783-8.
40. Shen Z, Wu A, Chen X. Current detection technologies for circulating tumor cells. Chem Soc Rev 2017;46:2038-56.
41. Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med 2015;7:1-11.
42. Deng G, Herrler M, Burgess D, Manna E, Krag D, et al. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM
antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Breast Cancer Res
2008;10:R69.
43. Andree KC, van Dalum G, Terstappen LW. Challenges in circulating tumor cell detection by the CellSearch system. Mol Oncol
2016;10:395-407.
44. Yu D, Sun X, Qiu Y, Zhou J, Wu Y, et al. Identification and clinical significance of mobilized endothelial progenitor cells in tumor
vasculogenesis of hepatocellular carcinoma. Clin Cancer Res 2007;13:3814-24.
45. Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, et al. Identification of local and circulating cancer stem cells in human liver cancer.
Hepatology 2008;47:919-28.
46. Liu S, Li N, Yu X, Xiao X, Cheng K, et al. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and
circulating tumor cells. Gastroenterology 2013;144:1031-41.e10.
47. Harouaka RA, Nisic M, Zheng SY. Circulating tumor cell enrichment based on physical properties. J Lab Autom 2013;18:455-68.
48. Song Y, Tian T, Shi Y, Liu W, Zou Y, et al. Enrichment and single-cell analysis of circulating tumor cells. Chem Sci 2017;8:1736-51.
49. Gertler R, Rosenberg R, Fuehrer K, Dahm M, Nekarda H, et al. Detection of circulating tumor cells in blood using an optimized density
gradient centrifugation. 2003;162:149.
50. Weitz J, Kienle P, Lacroix J, Willeke F, Benner A, et al. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer.
Clin Cancer Res 1998;4:343-8.
51. Rosenberg R, Gertler R, Friederichs J, Fuehrer K, Dahm M, et al. Comparison of two density gradient centrifugation systems for the
enrichment of disseminated tumor cells in blood. Cytometry 2002;49:150-8.